MIT Sloan BioInnovations Conference
March 12, 2010
 
Boston Marriott Cambridge Hotel
Kendall Square, Cambridge MA
 

 
Senior industry management, investors, and academics from the Massachusetts biotechnology community convene for a day of substantive idea exchange.

The Agenda

8:00

Registration and Morning Networking

9:00

Morning Keynote Speaker

Peter Wirth, Esquire

Executive Vice President, Genzyme Corporation

“Pharmaceutical Business Models – What’s Next?”

10:15

Morning Panels

11:45

Lunch and Networking

12:30

Afternoon Keynote Speaker

Dr. Robert Langer

David H. Koch Institute Professor, Massachusetts Institute of Technology

“Creating and implementing breakthrough medical technologies”

1:45

Afternoon Panels

3:15

Closing Keynote Speaker

Matt Emmens

Chairman, President and CEO, Vertex Pharmaceuticals